A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases
A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases
Active, not recruiting · NCT06076642 · Registry updated 2026-04-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Primary Immunodeficiency Diseases, hereditary disease, immune system disorder, inborn error of immunity | Active, not recruiting | Phase 3 | 2026-04-08 | NCT06076642 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Baxalta Innovations GmbH, now part of Takeda | 2 |
| Takeda | 163 |
| Takeda Development Center Americas, Inc. | 13 |
25 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.